UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma
Clinical trial NCT03322384 · COMPLETED
Trial details
- NCT number
- NCT03322384
- Sponsor
- University of California, Davis
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-17
- Primary completion
- 2020-02-24
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.